The analysis revealed an increasing trend in dexmedetomidine-associated adverse events cases annually from 2004 to 2023 Q3, with 223 cases reported in 2023 alone, the highest yearly count, representing 11.68% of the total.
← all excerpts
Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database.
1
—
—